ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 24 filers reported holding ADIAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,114 | +62.8% | 26,040 | 0.0% | 0.00% | – |
| Q4 2022 | $5,599 | -37.8% | 26,040 | 0.0% | 0.00% | – |
| Q3 2022 | $9,000 | -74.3% | 26,040 | 0.0% | 0.00% | – |
| Q2 2022 | $35,000 | -32.7% | 26,040 | 0.0% | 0.00% | – |
| Q1 2022 | $52,000 | -25.7% | 26,040 | 0.0% | 0.00% | – |
| Q4 2021 | $70,000 | -37.5% | 26,040 | 0.0% | 0.00% | – |
| Q3 2021 | $112,000 | +69.7% | 26,040 | 0.0% | 0.00% | – |
| Q2 2021 | $66,000 | +4.8% | 26,040 | 0.0% | 0.00% | – |
| Q1 2021 | $63,000 | +43.2% | 26,040 | 0.0% | 0.00% | – |
| Q4 2020 | $44,000 | -24.1% | 26,040 | 0.0% | 0.00% | – |
| Q3 2020 | $58,000 | +61.1% | 26,040 | 0.0% | 0.00% | – |
| Q2 2020 | $36,000 | +5.9% | 26,040 | 0.0% | 0.00% | – |
| Q1 2020 | $34,000 | -46.0% | 26,040 | 0.0% | 0.00% | – |
| Q4 2019 | $63,000 | +61.5% | 26,040 | 0.0% | 0.00% | – |
| Q3 2019 | $39,000 | -11.4% | 26,040 | 0.0% | 0.00% | – |
| Q2 2019 | $44,000 | -50.6% | 26,040 | 0.0% | 0.00% | – |
| Q1 2019 | $89,000 | – | 26,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|